Equity - Additional Information (Details) - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020	Jul. 31, 2022	Feb. 28, 2018
Stockholders Equity Note [Line Items]
Net proceeds from issuance of common stock	$ 68,035,000	$ 21,944,000	$ 5,881,000
Amount of shares repurchased during period	$ 56,496,000	$ 0	$ 21,659,000
Share Repurchase Program 2022
Stockholders Equity Note [Line Items]
Stock repurchase program, authorized amount				$ 125,000,000
Prior Share Repurchase Program
Stockholders Equity Note [Line Items]
Stock repurchase program, authorized amount					$ 100,000,000
Shares repurchased during period (in shares)	7,100,000
Share Repurchase Plan, February 2018
Stockholders Equity Note [Line Items]
Stock repurchase program, remaining authorized repurchase amount	$ 101,000,000
Convertible debt securities
Stockholders Equity Note [Line Items]
Securities excluded in the calculation of diluted earnings per share	40,081,997		31,306,089
Equity awards
Stockholders Equity Note [Line Items]
Securities excluded in the calculation of diluted earnings per share	226,975	18,736	12,622
Common Stock
Stockholders Equity Note [Line Items]
Issuance of common stock (in shares)	5,232,869	2,503,662	350,088
Direct stock purchase and dividend reinvestment plan (in shares)	0	100,000
Shares repurchased during period (in shares)	7,128,891	0	3,047,335
Amount of shares repurchased during period	$ 71,000	$ 0	$ 30,000
ATM Offerings | Common Stock
Stockholders Equity Note [Line Items]
Issuance of common stock (in shares)	5,200,000	1,600,000	100,000
Net proceeds from issuance of common stock	$ 67,000,000	$ 20,000,000	$ 2,000,000
Authorized issuance amount	$ 175,000,000
Direct Stock Purchases and Dividend Reinvestment Plan | Common Stock
Stockholders Equity Note [Line Items]
Net proceeds from issuance of common stock		$ 1,000,000
Remaining shares outstanding for future offerings (in shares)	6,000,000